SOSLAB Co., Ltd.

As of June 30, 2026, SOSLAB Co., Ltd. carries a market capitalization of 186.11B, placing it among publicly traded companies globally. Its enterprise value stands at 194.43B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, SOSLAB Co., Ltd. has 17.95M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 36.76, and the price-to-book ratio stands at 12.63.

These figures are as of June 30, 2026. The EV/Sales ratio of 38.66 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 194.43B versus a market cap of 186.11B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, SOSLAB Co., Ltd. maintains a current ratio of 6.66, meaning it holds 6.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 355.76, indicating elevated leverage, while an interest coverage ratio of -3.40 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, SOSLAB Co., Ltd. posted a negative return on equity (ROE) of -112.47, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -37.80, reflecting losses generated across the asset base. The company generates approximately 44.11M in revenue per employee across its workforce of 114.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.19 indicates how many times SOSLAB Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 23, 2026, SOSLAB Co., Ltd.'s stock has declined approximately 20.28% over the past 52 weeks. The 50-day moving average sits at 9,756.20, while the 200-day moving average is 13,575.00.

Over the twelve months ended June 30, 2026, SOSLAB Co., Ltd. generated 5.03B in revenue and converted that into -21.73B in net income, yielding earnings per share of -1,218.85. EBITDA reached -16.84B, while operating income came in at -18.19B.

As of June 30, 2026, SOSLAB Co., Ltd. holds 44.10B in cash and equivalents against 52.42B in total debt, resulting in a net debt position of 48.04B. Total book value stands at 14.74B, with working capital of 42.26B providing operational flexibility.

SOSLAB Co., Ltd. produced -14.54B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1.40B in capital expenditures, free cash flow totaled -15.94B - equivalent to -894.29 per share.

Over the twelve months ended June 30, 2026, SOSLAB Co., Ltd. posted a gross margin of 24.54, reflecting its pricing power and cost economics. The operating margin of -361.66 and net profit margin of -432.05 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -8.62: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -23.42, meaning SOSLAB Co., Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, SOSLAB Co., Ltd. has an Altman Z-Score of -0.14, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.